Phylogeny, Inc. Release: Central Ohio Companies Collaborate to Develop Novel Imaging Technology for Head and Neck Cancers
COLUMBUS, Ohio--(BUSINESS WIRE)--Phylogeny, the in situ company, and Neoprobe (OTCBB: NEOP), a diversified developer of innovative biomedical surgical oncology products, announce their collaboration to develop head and neck cancer detection technology.